GetTopicDetailResponse(id=09de86e7276, topicName=艾替班特, introduction=艾替班特, content=null, image=null, comments=2, allHits=1055, url=https://h5.medsci.cn/topic?id=86772, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=1266, tagList=[TagDto(tagId=1266, tagName=艾替班特)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2266288, encodeId=63b2226628845, content=<a href='/topic/show?id=09de86e7276' target=_blank style='color:#2F92EE;'>#艾替班特#</a> <a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遺傳性血管性水腫#</a>, objectTitle=莫名其妙就臉腫、肚子痛、喘不上氣？他被當(dāng)過(guò)敏治了10年，真相竟是罕見(jiàn)遺傳病！, objectType=article, longId=878629, objectId=9e768e8629ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720150214732_5579292.png, objectUrl=/article/show_article.do?id=9e768e8629ff, replyNumber=0, likeNumber=19, createdTime=2025-05-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9e768e8629ff, moduleTitle=莫名其妙就臉腫、肚子痛、喘不上氣？他被當(dāng)過(guò)敏治了10年，真相竟是罕見(jiàn)遺傳病！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9e768e8629ff)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2042524, encodeId=015b204252418, content=<a href='/topic/show?id=09de86e7276' target=_blank style='color:#2F92EE;'>#艾替班特#</a>, objectTitle=NEJM：艾替班特可用于治療ACE-抑制劑-誘導(dǎo)的血管性水腫, objectType=article, longId=47191, objectId=4cca4e19120, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cca4e19120, replyNumber=0, likeNumber=86, createdTime=2015-12-22, rootId=0, userName=changhe713, userId=56ea361, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cca4e19120, moduleTitle=NEJM：艾替班特可用于治療ACE-抑制劑-誘導(dǎo)的血管性水腫, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4cca4e19120)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042523, encodeId=6f132042523a4, content=<a href='/topic/show?id=09de86e7276' target=_blank style='color:#2F92EE;'>#艾替班特#</a>, objectTitle=FDA批準(zhǔn)艾替班特(Firazyr)治療遺傳性血管性水腫(HAE)急性發(fā)作, objectType=article, longId=3148, objectId=b2e131484c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2e131484c, replyNumber=0, likeNumber=86, createdTime=2012-02-07, rootId=0, userName=changhe713, userId=56ea361, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2e131484c, moduleTitle=FDA批準(zhǔn)艾替班特(Firazyr)治療遺傳性血管性水腫(HAE)急性發(fā)作, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b2e131484c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
